Report Detail
Global Ulcerative Colitis Treatment Market Insights, Forecast to 2025
- RnM2703948 |
- 22 May, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
The global Ulcerative Colitis Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ulcerative Colitis Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Ulcerative Colitis Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ulcerative Colitis Treatment in these regions.
This research report categorizes the global Ulcerative Colitis Treatment market by top players/brands, region, type and end user. This report also studies the global Ulcerative Colitis Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson.
AbbVie
Takeda Pharmaceuticals
Roche
Warner Chilcott
Salix Pharmaceuticals/Santarus
Shire Pharmaceuticals
Ferring Pharmaceuticals
Pfizer
InDeX Pharmaceuticals
Market size by Product
Oral
Injection
Market size by End User
Hospital
Drugs Stores
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ulcerative Colitis Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ulcerative Colitis Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ulcerative Colitis Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ulcerative Colitis Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ulcerative Colitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ulcerative Colitis Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Ulcerative Colitis Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Ulcerative Colitis Treatment Market Size Growth Rate by Product
- 1.4.2 Oral
- 1.4.3 Injection
- 1.5 Market by End User
- 1.5.1 Global Ulcerative Colitis Treatment Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Drugs Stores
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Ulcerative Colitis Treatment Market Size
- 2.1.1 Global Ulcerative Colitis Treatment Revenue 2014-2025
- 2.1.2 Global Ulcerative Colitis Treatment Sales 2014-2025
- 2.2 Ulcerative Colitis Treatment Growth Rate by Regions
- 2.2.1 Global Ulcerative Colitis Treatment Sales by Regions
- 2.2.2 Global Ulcerative Colitis Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Ulcerative Colitis Treatment Sales by Manufacturers
- 3.1.1 Ulcerative Colitis Treatment Sales by Manufacturers
- 3.1.2 Ulcerative Colitis Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Ulcerative Colitis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Ulcerative Colitis Treatment Revenue by Manufacturers
- 3.2.1 Ulcerative Colitis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Ulcerative Colitis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Ulcerative Colitis Treatment Price by Manufacturers
- 3.4 Ulcerative Colitis Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Ulcerative Colitis Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Ulcerative Colitis Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Ulcerative Colitis Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Ulcerative Colitis Treatment Sales by Product
- 4.2 Global Ulcerative Colitis Treatment Revenue by Product
- 4.3 Ulcerative Colitis Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Ulcerative Colitis Treatment Breakdown Data by End User
6 North America
- 6.1 North America Ulcerative Colitis Treatment by Countries
- 6.1.1 North America Ulcerative Colitis Treatment Sales by Countries
- 6.1.2 North America Ulcerative Colitis Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Ulcerative Colitis Treatment by Product
- 6.3 North America Ulcerative Colitis Treatment by End User
7 Europe
- 7.1 Europe Ulcerative Colitis Treatment by Countries
- 7.1.1 Europe Ulcerative Colitis Treatment Sales by Countries
- 7.1.2 Europe Ulcerative Colitis Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Ulcerative Colitis Treatment by Product
- 7.3 Europe Ulcerative Colitis Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Ulcerative Colitis Treatment by Countries
- 8.1.1 Asia Pacific Ulcerative Colitis Treatment Sales by Countries
- 8.1.2 Asia Pacific Ulcerative Colitis Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Ulcerative Colitis Treatment by Product
- 8.3 Asia Pacific Ulcerative Colitis Treatment by End User
9 Central & South America
- 9.1 Central & South America Ulcerative Colitis Treatment by Countries
- 9.1.1 Central & South America Ulcerative Colitis Treatment Sales by Countries
- 9.1.2 Central & South America Ulcerative Colitis Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Ulcerative Colitis Treatment by Product
- 9.3 Central & South America Ulcerative Colitis Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Ulcerative Colitis Treatment by Countries
- 10.1.1 Middle East and Africa Ulcerative Colitis Treatment Sales by Countries
- 10.1.2 Middle East and Africa Ulcerative Colitis Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Ulcerative Colitis Treatment by Product
- 10.3 Middle East and Africa Ulcerative Colitis Treatment by End User
11 Company Profiles
- 11.1 Johnson & Johnson.
- 11.1.1 Johnson & Johnson. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Johnson & Johnson. Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Johnson & Johnson. Ulcerative Colitis Treatment Products Offered
- 11.1.5 Johnson & Johnson. Recent Development
- 11.2 AbbVie
- 11.2.1 AbbVie Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AbbVie Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AbbVie Ulcerative Colitis Treatment Products Offered
- 11.2.5 AbbVie Recent Development
- 11.3 Takeda Pharmaceuticals
- 11.3.1 Takeda Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Takeda Pharmaceuticals Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Takeda Pharmaceuticals Ulcerative Colitis Treatment Products Offered
- 11.3.5 Takeda Pharmaceuticals Recent Development
- 11.4 Roche
- 11.4.1 Roche Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Roche Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Roche Ulcerative Colitis Treatment Products Offered
- 11.4.5 Roche Recent Development
- 11.5 Warner Chilcott
- 11.5.1 Warner Chilcott Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Warner Chilcott Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Warner Chilcott Ulcerative Colitis Treatment Products Offered
- 11.5.5 Warner Chilcott Recent Development
- 11.6 Salix Pharmaceuticals/Santarus
- 11.6.1 Salix Pharmaceuticals/Santarus Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Salix Pharmaceuticals/Santarus Ulcerative Colitis Treatment Products Offered
- 11.6.5 Salix Pharmaceuticals/Santarus Recent Development
- 11.7 Shire Pharmaceuticals
- 11.7.1 Shire Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Shire Pharmaceuticals Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Shire Pharmaceuticals Ulcerative Colitis Treatment Products Offered
- 11.7.5 Shire Pharmaceuticals Recent Development
- 11.8 Ferring Pharmaceuticals
- 11.8.1 Ferring Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Ferring Pharmaceuticals Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Ferring Pharmaceuticals Ulcerative Colitis Treatment Products Offered
- 11.8.5 Ferring Pharmaceuticals Recent Development
- 11.9 Pfizer
- 11.9.1 Pfizer Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Pfizer Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Pfizer Ulcerative Colitis Treatment Products Offered
- 11.9.5 Pfizer Recent Development
- 11.10 InDeX Pharmaceuticals
- 11.10.1 InDeX Pharmaceuticals Company Details
- 11.10.2 Company Business Overview
- 11.10.3 InDeX Pharmaceuticals Ulcerative Colitis Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 InDeX Pharmaceuticals Ulcerative Colitis Treatment Products Offered
- 11.10.5 InDeX Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Ulcerative Colitis Treatment Market Forecast by Regions
- 12.1.1 Global Ulcerative Colitis Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Ulcerative Colitis Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Ulcerative Colitis Treatment Market Forecast by Product
- 12.2.1 Global Ulcerative Colitis Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Ulcerative Colitis Treatment Revenue Forecast by Product 2019-2025
- 12.3 Ulcerative Colitis Treatment Market Forecast by End User
- 12.4 North America Ulcerative Colitis Treatment Forecast
- 12.5 Europe Ulcerative Colitis Treatment Forecast
- 12.6 Asia Pacific Ulcerative Colitis Treatment Forecast
- 12.7 Central & South America Ulcerative Colitis Treatment Forecast
- 12.8 Middle East and Africa Ulcerative Colitis Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Ulcerative Colitis Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Ulcerative Colitis Treatment . Industry analysis & Market Report on Ulcerative Colitis Treatment is a syndicated market report, published as Global Ulcerative Colitis Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ulcerative Colitis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
